Ok i see a lot of BS on this board, look other then one other drug, this is it for anemic dialysis patients. So the is a need for it, yes peoole have died, but an investigation is under way to figure out why, and possibly human error, is it million dollar drug yes, so alot of time is gona be need to assure that the drug is safe, will the stock drop more sure maybe, but those that know its a drug that is needed, now its a great buy, news will come out and it will pop, so GLTA that are holding and those that are now buying, to others that bash well to fly a kite, any thoughts are welcomed
According to AFFY's latest 10Q, "IF" Omontys ever returns to market certainly remains in the equation and AFFY says it remains both "CHALLENGING" and "HIGHLY UNCERTAIN". Moreover, even though 8 months have passed since O's recall, AFFY expects Takeda's root cause investigation is expected to "REMAIN LENGTHY". Doesn't sound like just a matter of "when" to me.